 | • レポートコード：MRC2012A7933 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、レミケード（インフリキシマブ）医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。レミケード（インフリキシマブ）医薬品の種類別市場規模（ブランド薬品、ジェネリック薬品）、用途別市場規模（クローン病、小児クローン病、潰瘍性大腸炎、小児潰瘍性大腸炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Janssen、Epirus Biopharmaceuticals、Hospira、Celltrion Healthcare、Samsung Bioepsis、 ・地域別グローバル市場分析 2015年-2020年 ・レミケード（インフリキシマブ）医薬品の北米市場（アメリカ、カナダ、メキシコ） ・レミケード（インフリキシマブ）医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・レミケード（インフリキシマブ）医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・レミケード（インフリキシマブ）医薬品の南米市場（ブラジル、アルゼンチン） ・レミケード（インフリキシマブ）医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ブランド薬品、ジェネリック薬品 ・用途別分析：クローン病、小児クローン病、潰瘍性大腸炎、小児潰瘍性大腸炎、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Remicade (infliximab) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Remicade (infliximab) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Remicade (infliximab) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Remicade (infliximab) Drug market has been segmented into
Brands Drugs
Generic Drugs
By Application, Remicade (infliximab) Drug has been segmented into:
Crohn’s Disease
Pediatric Crohn’s Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Remicade (infliximab) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Remicade (infliximab) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Remicade (infliximab) Drug market.
The report offers in-depth assessment of the growth and other aspects of the Remicade (infliximab) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Remicade (infliximab) Drug Market Share Analysis
Remicade (infliximab) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Remicade (infliximab) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Remicade (infliximab) Drug sales, revenue and market share for each player covered in this report.
The major players covered in Remicade (infliximab) Drug are:
Janssen
Epirus Biopharmaceuticals
Hospira
Celltrion Healthcare
Samsung Bioepsis
Among other players domestic and global, Remicade (infliximab) Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Remicade (infliximab) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Remicade (infliximab) Drug, with price, sales, revenue and global market share of Remicade (infliximab) Drug in 2018 and 2019.
Chapter 3, the Remicade (infliximab) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Remicade (infliximab) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Remicade (infliximab) Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Remicade (infliximab) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Remicade (infliximab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Remicade (infliximab) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Brands Drugs
1.2.3 Generic Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Remicade (infliximab) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Crohn’s Disease
1.3.3 Pediatric Crohn’s Disease
1.3.4 Ulcerative Colitis
1.3.5 Pediatric Ulcerative Colitis
1.3.6 Other
1.4 Overview of Global Remicade (infliximab) Drug Market
1.4.1 Global Remicade (infliximab) Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Janssen
2.1.1 Janssen Details
2.1.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Janssen SWOT Analysis
2.1.4 Janssen Product and Services
2.1.5 Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Epirus Biopharmaceuticals
2.2.1 Epirus Biopharmaceuticals Details
2.2.2 Epirus Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Epirus Biopharmaceuticals SWOT Analysis
2.2.4 Epirus Biopharmaceuticals Product and Services
2.2.5 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hospira
2.3.1 Hospira Details
2.3.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hospira SWOT Analysis
2.3.4 Hospira Product and Services
2.3.5 Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celltrion Healthcare
2.4.1 Celltrion Healthcare Details
2.4.2 Celltrion Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celltrion Healthcare SWOT Analysis
2.4.4 Celltrion Healthcare Product and Services
2.4.5 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Samsung Bioepsis
2.5.1 Samsung Bioepsis Details
2.5.2 Samsung Bioepsis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Samsung Bioepsis SWOT Analysis
2.5.4 Samsung Bioepsis Product and Services
2.5.5 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Remicade (infliximab) Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Remicade (infliximab) Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Remicade (infliximab) Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Remicade (infliximab) Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Remicade (infliximab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Remicade (infliximab) Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Remicade (infliximab) Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
4.3 Europe Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
4.5 South America Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Remicade (infliximab) Drug Sales, Revenue and Market Share by Country
5.1.1 North America Remicade (infliximab) Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Remicade (infliximab) Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
5.3 Canada Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Remicade (infliximab) Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Remicade (infliximab) Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Remicade (infliximab) Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
6.3 UK Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
6.4 France Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
6.5 Russia Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
6.6 Italy Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Remicade (infliximab) Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Remicade (infliximab) Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Remicade (infliximab) Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
7.3 Japan Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
7.4 Korea Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
7.5 India Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
7.7 Australia Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Remicade (infliximab) Drug Sales, Revenue and Market Share by Country
8.1.1 South America Remicade (infliximab) Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Remicade (infliximab) Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Remicade (infliximab) Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Remicade (infliximab) Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Remicade (infliximab) Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Remicade (infliximab) Drug Sales and Market Share by Type (2015-2020)
10.2 Global Remicade (infliximab) Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Remicade (infliximab) Drug Price by Type (2015-2020)
11 Global Remicade (infliximab) Drug Market Segment by Application
11.1 Global Remicade (infliximab) Drug Sales Market Share by Application (2015-2020)
11.2 Global Remicade (infliximab) Drug Revenue Market Share by Application (2015-2020)
11.3 Global Remicade (infliximab) Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Remicade (infliximab) Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Remicade (infliximab) Drug Market Forecast (2021-2025)
12.2.2 Europe Remicade (infliximab) Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Remicade (infliximab) Drug Market Forecast (2021-2025)
12.2.4 South America Remicade (infliximab) Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Remicade (infliximab) Drug Market Forecast (2021-2025)
12.3 Remicade (infliximab) Drug Market Forecast by Type (2021-2025)
12.3.1 Global Remicade (infliximab) Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Remicade (infliximab) Drug Market Share Forecast by Type (2021-2025)
12.4 Remicade (infliximab) Drug Market Forecast by Application (2021-2025)
12.4.1 Global Remicade (infliximab) Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Remicade (infliximab) Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Remicade (infliximab) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Remicade (infliximab) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Remicade (infliximab) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Janssen Basic Information, Manufacturing Base and Competitors
Table 8. Janssen Remicade (infliximab) Drug Major Business
Table 9. Janssen Remicade (infliximab) Drug Total Revenue (USD Million) (2017-2018)
Table 10. Janssen SWOT Analysis
Table 11. Janssen Remicade (infliximab) Drug Product and Services
Table 12. Janssen Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Epirus Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Epirus Biopharmaceuticals Remicade (infliximab) Drug Major Business
Table 15. Epirus Biopharmaceuticals Remicade (infliximab) Drug Total Revenue (USD Million) (2017-2018)
Table 16. Epirus Biopharmaceuticals SWOT Analysis
Table 17. Epirus Biopharmaceuticals Remicade (infliximab) Drug Product and Services
Table 18. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Hospira Basic Information, Manufacturing Base and Competitors
Table 20. Hospira Remicade (infliximab) Drug Major Business
Table 21. Hospira Remicade (infliximab) Drug Total Revenue (USD Million) (2017-2018)
Table 22. Hospira SWOT Analysis
Table 23. Hospira Remicade (infliximab) Drug Product and Services
Table 24. Hospira Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Celltrion Healthcare Basic Information, Manufacturing Base and Competitors
Table 26. Celltrion Healthcare Remicade (infliximab) Drug Major Business
Table 27. Celltrion Healthcare Remicade (infliximab) Drug Total Revenue (USD Million) (2017-2018)
Table 28. Celltrion Healthcare SWOT Analysis
Table 29. Celltrion Healthcare Remicade (infliximab) Drug Product and Services
Table 30. Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Samsung Bioepsis Basic Information, Manufacturing Base and Competitors
Table 32. Samsung Bioepsis Remicade (infliximab) Drug Major Business
Table 33. Samsung Bioepsis Remicade (infliximab) Drug Total Revenue (USD Million) (2017-2018)
Table 34. Samsung Bioepsis SWOT Analysis
Table 35. Samsung Bioepsis Remicade (infliximab) Drug Product and Services
Table 36. Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Remicade (infliximab) Drug Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Remicade (infliximab) Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Remicade (infliximab) Drug Sales by Regions (2015-2020) (K Units)
Table 40. Global Remicade (infliximab) Drug Sales Market Share by Regions (2015-2020)
Table 41. Global Remicade (infliximab) Drug Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Remicade (infliximab) Drug Sales by Countries (2015-2020) (K Units)
Table 43. North America Remicade (infliximab) Drug Sales Market Share by Countries (2015-2020)
Table 44. North America Remicade (infliximab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Remicade (infliximab) Drug Revenue Market Share by Countries (2015-2020)
Table 46. Europe Remicade (infliximab) Drug Sales by Countries (2015-2020) (K Units)
Table 47. Europe Remicade (infliximab) Drug Sales Market Share by Countries (2015-2020)
Table 48. Europe Remicade (infliximab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Remicade (infliximab) Drug Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Remicade (infliximab) Drug Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Remicade (infliximab) Drug Sales by Countries (2015-2020) (K Units)
Table 53. South America Remicade (infliximab) Drug Sales Market Share by Countries (2015-2020)
Table 54. South America Remicade (infliximab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Remicade (infliximab) Drug Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Remicade (infliximab) Drug Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Remicade (infliximab) Drug Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Remicade (infliximab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Remicade (infliximab) Drug Revenue Market Share by Countries (2015-2020)
Table 60. Global Remicade (infliximab) Drug Sales by Type (2015-2020) (K Units)
Table 61. Global Remicade (infliximab) Drug Sales Share by Type (2015-2020)
Table 62. Global Remicade (infliximab) Drug Revenue by Type (2015-2020) (USD Million)
Table 63. Global Remicade (infliximab) Drug Revenue Share by Type (2015-2020)
Table 64. Global Remicade (infliximab) Drug Sales by Application (2015-2020) (K Units)
Table 65. Global Remicade (infliximab) Drug Sales Share by Application (2015-2020)
Table 66. Global Remicade (infliximab) Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Remicade (infliximab) Drug Market Share Forecast by Regions (2021-2025)
Table 68. Global Remicade (infliximab) Drug Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Remicade (infliximab) Drug Market Share Forecast by Type (2021-2025)
Table 70. Global Remicade (infliximab) Drug Sales Forecast by Application (2021-2025)
Table 71. Global Remicade (infliximab) Drug Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Remicade (infliximab) Drug Picture
Figure 2. Global Sales Market Share of Remicade (infliximab) Drug by Type in 2019
Figure 3. Brands Drugs Picture
Figure 4. Generic Drugs Picture
Figure 5. Remicade (infliximab) Drug Sales Market Share by Application in 2018
Figure 6. Crohn's Disease Picture
Figure 7. Pediatric Crohn's Disease Picture
Figure 8. Ulcerative Colitis Picture
Figure 9. Pediatric Ulcerative Colitis Picture
Figure 10. Other Picture
Figure 11. Global Remicade (infliximab) Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Remicade (infliximab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Remicade (infliximab) Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Remicade (infliximab) Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Remicade (infliximab) Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Remicade (infliximab) Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Remicade (infliximab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Remicade (infliximab) Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Remicade (infliximab) Drug Revenue Market Share by Regions in 2018
Figure 40. North America Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Remicade (infliximab) Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Remicade (infliximab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Remicade (infliximab) Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Remicade (infliximab) Drug Sales Market Share by Countries in 2018
Figure 48. North America Remicade (infliximab) Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Remicade (infliximab) Drug Revenue Market Share by Countries in 2018
Figure 50. United States Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Remicade (infliximab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Remicade (infliximab) Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Remicade (infliximab) Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Remicade (infliximab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Remicade (infliximab) Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Remicade (infliximab) Drug Revenue Market Share by Regions 2019
Figure 64. China Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Remicade (infliximab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Remicade (infliximab) Drug Sales Market Share by Countries in 2019
Figure 71. South America Remicade (infliximab) Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Remicade (infliximab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Remicade (infliximab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Remicade (infliximab) Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Remicade (infliximab) Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Remicade (infliximab) Drug Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Remicade (infliximab) Drug Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Remicade (infliximab) Drug Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Remicade (infliximab) Drug Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Remicade (infliximab) Drug Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
潰瘍性大腸炎免疫治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ulcerative Colitis Immunology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ulcerativ…- 潰瘍性大腸炎免疫薬 の世界市場（～2026年） Market Analysis and Insights: Global Ulcerative Colitis Immunology Drugs Market The global Ulcerative Colitis Immunology Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ulcerative Colitis Immunology Drugs Scope a…
- 潰瘍性大腸炎治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drug for Ulcerative Colitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug for Ulcerati…
- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…
- 潰瘍性大腸炎の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Ulcerative Colitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ulcerative Colitis market …